Does Reglan (Metoclopramide) Cause Hypotension?
Reglan can cause hypotension, though this is not a common side effect, and the FDA drug label does not list hypotension as a primary adverse effect. However, the evidence shows that hypotension can occur, particularly with intravenous administration, and may be more pronounced in certain patient populations.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for Reglan mentions that in hypertensive patients, intravenously administered metoclopramide was shown to release catecholamines; hence, caution should be exercised when metoclopramide is used in patients with hypertension 1. The drug label also notes that patients should be informed about high blood pressure as a condition requiring caution, but does not prominently feature hypotension as a common adverse effect 1.
Clinical Evidence of Hypotension
Acute Hypotensive Effects
Research demonstrates that metoclopramide can indeed lower blood pressure:
A case report documented sustained hypotension lasting approximately 90 minutes after IV metoclopramide 10 mg administration, with systolic blood pressure dropping from 138 to 84 mmHg (mean arterial pressure decrease of 40.7 mmHg) 2. This represents the first published case of sustained hypotension from IV metoclopramide.
In patients with autonomic dysfunction (multiple system atrophy and pure autonomic failure), metoclopramide caused transient hypotension after each infusion, with progressive reduction in mean arterial pressure that never returned to baseline levels 3. This effect was severe enough to prevent some patients from receiving full dosing.
In normotensive and hypertensive subjects, IV metoclopramide decreased blood pressure, with the effect being greater in hypertensive subjects and untrained individuals 4.
Mechanism and Clinical Context
The hypotensive effect appears to be:
- Transient and dose-related, occurring after each infusion
- More pronounced in patients with autonomic dysfunction or those unable to mount compensatory tachycardia 3
- Counterbalanced by reflex tachycardia in healthy individuals with intact autonomic function 3
- Potentially enhanced when combined with other antihypertensive medications like labetalol 5
Clinical Guidelines Context
In clinical practice guidelines, hypotension is mentioned as a manageable side effect:
- For migraine treatment, metoclopramide is listed with adverse reactions including "hypotension" among other effects like restlessness and drowsiness 6
- Guidelines for nausea and vomiting in pregnancy recommend slow IV administration (over at least 3 minutes) to minimize risks, though this primarily addresses extrapyramidal effects rather than hypotension 7
Important Clinical Caveats
Use caution in specific populations:
- Patients with autonomic dysfunction or orthostatic hypotension should generally avoid metoclopramide, as it can worsen blood pressure control 3
- Patients taking concurrent antihypertensive medications may experience enhanced hypotensive effects 5
- Slow IV administration is recommended to minimize acute cardiovascular effects 7
The hypotensive effect is generally:
- Self-limited in patients with normal autonomic function
- More problematic with IV than oral administration
- Rarely severe enough to cause clinical concern in otherwise healthy patients
Bottom line: While hypotension is not a prominent or common side effect of Reglan, it can occur, particularly with IV administration. The risk is substantially higher in patients with autonomic dysfunction or those on concurrent antihypertensive therapy. In routine clinical use for nausea/vomiting in otherwise healthy patients, clinically significant hypotension is uncommon but should be monitored, especially with parenteral administration.